Along with weight loss, exercise, and nutrition, employers now target sleep improvements in employees; a Republican member of the FTC supports Medicare drug price negotiations; sepsis is likely responsible for 20% of deaths worldwide.
Employers are focusing on improvements in workers’ sleep as a way to reduce company medical costs and improve employee health, according to Kaiser Health News. This new area of focus comes after wellness issues like weight loss, exercise, and nutrition were targeted by employers in the past. One company included in the article, Southern Co, has screened around 4000 of its 30,000 employees for sleep apnea in the past 3 years and saw a $1.2-million reduction in medical costs in 2018. One in 4 large employers offer programs to assist workers in improving sleep, the article reports, but the long-term effects remain unknown.
Christine Wilson, the Republican commissioner of the Federal Trade Commission (FTC) appointed by President Trump, expressed her support for Medicare negotiations on drug prices, The Hill reports. Speaking at a health care conference in Washington, DC, Wilson broke ranks from her Republican colleagues, who have historically opposed the notion. “I think part of the problem is that the federal government has not been able to negotiate under certain parts of Medicare and Medicaid for pharmaceutical prices,” Wilson said. Democrats passed a bill in the House in December addressing the issue, but the President and Senate Republicans rejected it.
A recent study published in Lancet lists sepsis, sometimes called blood poisoning, as a major contributor to deaths around the world. The disease arises when a body overreacts to an infection, which can lead to multiple-organ failure, NPR reports. About 270,000 deaths occur as a result of the disease in the United States each year, but the global death rate has dropped by about half since 1990. The study analyzed more than 100 million death certificates between 1990 and 2007 and concluded that sepsis is twice as common as previously thought. In 2017, researchers determined 11 million people worldwide died from the disease out of 56 million deaths.
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
The Impact of Nurse Practitioner Attribution in Medicare Shared Savings ACOs
December 5th 2023Allowing nurse practitioners to serve as attribution-eligible providers for Medicare Shared Savings Program accountable care organizations leads to no change in hierarchical condition category risk scores and modest growth in attributed beneficiaries.
Read More